Pacer Advisors, Inc. Vbi Vaccines Inc Transaction History

Pacer Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$2.61 - $4.17 $63,036 - $100,713	-24,152 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$2.91 - $4.32 $46,880 - $69,595	-16,110 Reduced 40.01%	24,152 $75,000
Q4 2020 Jan 20, 2021	BUY	$2.15 - $3.5 $86,563 - $140,917	40,262 New	40,262 $111,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.